Why Healthcare Organizations Need to Understand Both GDPR and HIPAA
The globalization of healthcare delivery has made multi-jurisdictional compliance an operational necessity rather than a theoretical concern. A European hospital system using a US-developed EHR platform must comply with GDPR for its EU patient data while ensuring its vendor meets HIPAA standards for any US data processing. A US telehealth provider treating patients across state lines and increasingly across borders must navigate HIPAA domestically and potentially GDPR if treating EU residents. Healthcare SaaS platforms serving international clients face the most complex scenario: simultaneous compliance with multiple overlapping regulatory frameworks.
The consequences of non-compliance are severe under both regimes. GDPR penalties can reach up to 4% of annual global turnover or 20 million euros, whichever is higher. HIPAA violations carry civil penalties ranging from $137 per violation (for unknowing violations) to $68,928 per violation (for willful neglect not corrected), with annual caps of $2,067,813 per violation category. Criminal penalties under HIPAA can include fines up to $250,000 and imprisonment up to 10 years for intentional misuse of patient information.
Beyond financial penalties, both frameworks carry significant reputational risk. Healthcare data breaches generate intense media scrutiny, erode patient trust, and can trigger class-action lawsuits. The IBM Cost of a Data Breach Report consistently ranks healthcare as the most expensive sector for data breaches, with an average cost of $10.93 million per incident in 2024. Understanding both frameworks thoroughly is not optional — it is a fundamental business requirement for any healthcare organization operating internationally or using cloud-based technology.
Scope and Applicability: Who Must Comply?
GDPR and HIPAA differ fundamentally in scope. GDPR is a general data protection regulation that applies to all personal data processing, not just healthcare. It applies to any organization that processes personal data of EU/EEA residents, regardless of where the organization is located. This extraterritorial reach means a US healthcare SaaS company with EU customers must comply with GDPR for those customers' data, even if the company has no physical presence in Europe.
HIPAA, by contrast, is sector-specific. It applies only to covered entities (healthcare providers who conduct electronic transactions, health plans, and healthcare clearinghouses) and their business associates (entities that handle protected health information on behalf of covered entities). A technology company that processes health data but does not fall into these categories is not directly subject to HIPAA — though it may be bound by HIPAA requirements through business associate agreements (BAAs).
The types of data protected also differ. GDPR protects all personal data — any information relating to an identified or identifiable natural person. Health data is classified as a 'special category' of personal data under Article 9, subject to additional protections. HIPAA protects only Protected Health Information (PHI) — individually identifiable health information held or transmitted by a covered entity or its business associates. PHI includes medical records, billing information, and any health data that can be linked to an individual.
This scope difference has practical implications. Under GDPR, a patient's name, email, IP address, and appointment scheduling data are all personal data requiring protection — even if no clinical information is involved. Under HIPAA, the same data is PHI only if it is held by a covered entity or business associate in connection with healthcare services.
Consent, Legal Basis, and Patient Rights
GDPR requires a specific legal basis for every data processing activity, with six possible bases defined in Article 6: consent, contract performance, legal obligation, vital interests, public interest, and legitimate interests. For health data processing under Article 9, the legal basis is further restricted — explicit consent is the most commonly used basis for healthcare, though exceptions exist for healthcare provision (Article 9(2)(h)) and public health purposes (Article 9(2)(i)).
HIPAA does not use a consent-based framework for most healthcare operations. The HIPAA Privacy Rule permits covered entities to use and disclose PHI for treatment, payment, and healthcare operations (TPO) without patient authorization. Patient authorization (the HIPAA equivalent of consent) is required only for uses outside TPO — such as marketing, sale of PHI, or research. Patients must receive a Notice of Privacy Practices explaining how their information may be used, but they do not typically need to sign a consent form for routine clinical and billing activities.
Patient rights represent another significant divergence. GDPR grants data subjects extensive rights: access to their data, rectification of inaccuracies, erasure ('right to be forgotten'), data portability in machine-readable format, restriction of processing, and the right to object to processing. The right to erasure is particularly challenging in healthcare contexts where records retention is mandated by other regulations.
HIPAA grants patients the right to access their PHI, request amendments, receive an accounting of disclosures, request restrictions on certain uses, and request confidential communications. However, HIPAA does not include a right to erasure — covered entities are required to maintain records for specified retention periods (typically 6-10 years depending on state law). The right to data portability under HIPAA is more limited than GDPR, though the 21st Century Cures Act and ONC's information blocking rules have expanded patient access requirements.
Security Requirements: Technical and Organizational Measures
Both GDPR and HIPAA require appropriate security measures, but they differ in specificity. GDPR Article 32 requires 'appropriate technical and organizational measures' based on the nature, scope, context, and purposes of processing, as well as the risk to data subjects. It specifically mentions pseudonymization, encryption, confidentiality/integrity/availability/resilience of systems, regular testing, and the ability to restore data after an incident. However, GDPR is deliberately technology-neutral and does not prescribe specific technical implementations.
The HIPAA Security Rule is more prescriptive, specifying three categories of safeguards. Administrative safeguards include risk analysis, workforce training, access management, contingency planning, and business associate management. Physical safeguards cover facility access controls, workstation security, and device/media controls. Technical safeguards address access controls, audit controls, integrity controls, and transmission security. Within these categories, some specifications are 'required' (must be implemented) and others are 'addressable' (must be implemented or documented as to why an alternative measure is equally effective).
Encryption illustrates the difference. GDPR mentions encryption as one possible security measure but does not mandate it. HIPAA classifies encryption as addressable for data at rest and required for data in transit — though proposed HIPAA Security Rule updates would make encryption required in both scenarios. In practice, healthcare organizations complying with both frameworks implement AES-256 encryption for all PHI/personal data at rest and in transit, which satisfies the most stringent interpretation of both regulations.
Breach notification requirements also differ. GDPR requires notification to the supervisory authority within 72 hours of becoming aware of a personal data breach, and notification to affected individuals without undue delay if the breach is likely to result in high risk. HIPAA requires notification to affected individuals within 60 days, notification to HHS, and for breaches affecting 500+ individuals, notification to prominent media outlets in the affected state.
Cross-Border Data Transfers: The Most Complex Challenge
Cross-border data transfer is the area where GDPR and HIPAA compliance most frequently conflict for international healthcare organizations. GDPR Chapter V restricts transfers of personal data to countries outside the EU/EEA unless the destination country has been granted an adequacy decision by the European Commission, or appropriate safeguards are in place (Standard Contractual Clauses, Binding Corporate Rules, or certification mechanisms).
The EU-US Data Privacy Framework (DPF), adopted in July 2023, provides a legal mechanism for transferring personal data from the EU to certified US organizations. Healthcare organizations relying on the DPF must self-certify and comply with the framework's principles, including notice, choice, accountability for onward transfer, security, data integrity, access, and recourse. However, the DPF's long-term stability remains uncertain — its predecessor (Privacy Shield) was invalidated by the Court of Justice of the EU in the Schrems II decision.
HIPAA has no explicit cross-border transfer restrictions. PHI can be stored and processed anywhere, provided that the entity processing the data is bound by a BAA and implements the required security safeguards. This asymmetry creates challenges: a US covered entity can freely process EU patient data under HIPAA, but the same data transfer may violate GDPR if adequate transfer mechanisms are not in place.
Practical solutions for dual compliance include: maintaining regional data centers (processing EU data in the EU, US data in the US), implementing Standard Contractual Clauses for any necessary cross-border transfers, conducting Transfer Impact Assessments documenting the legal framework of the destination country, and implementing supplementary technical measures (encryption, pseudonymization) to protect transferred data from foreign government access. Healthcare SaaS platforms serving international clients must architect their infrastructure to support data residency requirements while maintaining operational efficiency.
How On-Kare Handles Dual GDPR-HIPAA Compliance
On-Kare is architected for multi-jurisdictional compliance from the ground up, implementing a 'highest common denominator' approach that satisfies the most stringent requirements of both GDPR and HIPAA — plus 28 additional country-specific healthcare regulations.
Data residency: On-Kare operates regional data centers in the EU, US, and APAC. Patient data is processed and stored in the region corresponding to the patient's jurisdiction, eliminating most cross-border transfer concerns. When cross-border transfer is necessary (e.g., for international multi-site organizations), the platform implements Standard Contractual Clauses and supplementary technical measures automatically.
Security: The platform implements AES-256 encryption for all data at rest and in transit (satisfying both GDPR Article 32 and HIPAA Security Rule requirements), multi-factor authentication, role-based access control with least-privilege principles, comprehensive audit logging, and automated access reviews. ISO 27001 certification and a SOC 2 Type II report (available under NDA) provide independent validation of security controls.
Consent and rights management: On-Kare's compliance engine automatically applies the correct consent and patient rights framework based on the patient's jurisdiction. EU patients receive GDPR-compliant consent flows with granular purpose specification and easy withdrawal. US patients receive HIPAA-compliant Notice of Privacy Practices and authorization forms for non-TPO uses. The platform supports data subject access requests (GDPR Article 15), right to rectification (Article 16), and right to data portability (Article 20), as well as HIPAA access and amendment rights.
Breach management: On-Kare maintains automated breach detection with configurable notification workflows that satisfy both GDPR's 72-hour authority notification requirement and HIPAA's 60-day individual notification requirement. The platform generates pre-formatted breach notification reports for supervisory authorities (GDPR) and HHS (HIPAA).
Business associate management: On-Kare provides standard BAAs for US covered entity clients and Data Processing Agreements (DPAs) for EU clients, ensuring contractual compliance under both frameworks. The platform maintains a register of all sub-processors with their data processing activities, as required by GDPR Article 30 and HIPAA Business Associate provisions.
For healthcare organizations operating across jurisdictions, On-Kare eliminates the need to maintain separate systems or compliance programs for different regulatory regimes — providing unified compliance management through a single platform.